Clinical Trial Update: ALK21-004: Single-dose Opiate Challenge of Medisorb® Naltrexone (VIVITROL®) in Adults Who Use Opioids [Phase 2]

View source ↗

Summary

Phase 2 trial update reporting results of a single-dose opiate challenge using Medisorb Naltrexone (VIVITROL) in adults with opioid use disorder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid Use Disorder

Drugs mentioned

• Vivitrol (naltrexone extended-release injectable)

Snippet

Sponsor: Alkermes, Inc. | Conditions: Opiate Dependence | Phase 2 | Status: COMPLETED | Results posted: 2010-12-13